Molecular Analysis of the Na+channel Blocking Actions of the Novel Class I Anti-Arrhythmic Agent RSD 921

British Journal of Pharmacology - United States
doi 10.1038/sj.bjp.0702488
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Anti-Inflammatory Actions of Glucocorticoids: Molecular Mechanisms

Clinical Science
Medicine
1998English

Atomic Basis for Potassium Channel Potentiation by a Novel Class of Anti-Epileptic Drugs

Biophysical Journal
Biophysics
2015English

The Law and Economics of Class Actions

European Journal of Law and Economics
LawEconomicsInternational ManagementBusinessEconometrics
2011English

Safety, Tolerability, and Pharmacokinetics of the Novel Anti-Influenza Agent Baloxavir Marboxil in Healthy Adults: Phase I Study Findings

Clinical Drug Investigation
MedicinePharmacology
2018English

The Clinical Outcomes of Patients Who Developed Typical Atrial Flutter on Class 1C Anti Arrhythmic Medications Treated With Hybrid Approach

Clinical Cardiology
MedicineCardiovascular MedicineCardiology
2019English

Developing a Novel Class of CLC Chloride-Channel Inhibitors

Biophysical Journal
Biophysics
2017English

Insights Into the Molecular Mechanisms of the Anti-Atherogenic Actions of Flavonoids in Normal and Obese Mice

PLoS ONE
Multidisciplinary
2011English

Electrophysiology of the Novel Class III Agent, Ibutilide, in the Neonatal Heart - Rate-Dependent Characteristics

Pediatric Research
Child HealthPediatricsPerinatology
1999English

Effect of a Class III Anti-Arrthythmic Agent MS-551 on Na+ Current in Guinea Pig Ventricular Myocyte.

Japanese Journal of Electrocardiology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy